Download PDF
Dtsch Med Wochenschr 2006; 131(47): 2657-2660
DOI: 10.1055/s-2006-956271
Prinzip & Perspektive | Review article
Gastroenterologie/Immunologie
© Georg Thieme Verlag KG Stuttgart · New York

Immunbiologie chronisch-entzündlicher Darmerkrankungen

Immunobiology of inflammatory bowel diseasesB. Siegmund1 , M. Zeitz1
  • 1Medizinische Klinik I, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin
Further Information

Publication History

eingereicht: 14.3.2006

akzeptiert: 20.7.2006

Publication Date:
16 November 2006 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Morbus Crohn - Colitis ulcerosa - mukosales Immunsystem

Key-words

Crohn’s disease - ulcerative colitis - mucosal immune system

Literatur

  • 1 Bamias A, Nyce M R, De La Rue S A, Cominelli F. New concepts in the pathophysiology of inflammatory bowel disease.  Ann Intern Med. 2005;  143 895-904
    Search in Google Scholar
  • 2 Elliott D E, Summers R W, Weinstock J V. Helminths and the modulation of mucosal inflammation.  Curr Opin Gastroenterol. 2005;  21 51-58
    Search in Google Scholar
  • 3 Kruis W. Review article: antibiotics and probiotics in inflammatory bowel disease.  Aliment Pharmacol Ther. 2004;  20 (Suppl 4) 75-78
    Search in Google Scholar
  • 4 Mannon P J, Fuss I J, Mayer L. et al . Anti-interleukin-12 antibody for active Crohn’s disease.  N Engl J Med. 2004;  351 2069-2079
    Search in Google Scholar
  • 5 Podolsky D K. Selective adhesion-molecule therapy and inflammatory bowel disease - a tale of Janus?.  N Engl J Med. 2005;  353 1965-1968
    Search in Google Scholar
  • 6 Rutgeerts P, Sandborn W J, Feagan B G. et al . Infliximab for induction and maintenance therapy for ulcerative colitis.  N Engl J Med. 2005;  353 2462-2476
    Search in Google Scholar

Priv.-Doz. Dr. med. Britta Siegmund

Charité Campus Benjamin Franklin, Medizinische Klinik I

Hindenburgdamm 30

12200 Berlin

Phone: 030/84454039

Fax: 030/84454017

Email: britta.siegmund@charite.de